Our specialists are actively involved in clinical trials and translational research, which have the potential to improve survival rates or quality of life in patients with brain tumors.
Clinical trials give you access to new, promising therapies when appropriate or provide additional options if your tumor has returned. They may include a new drug or combination of drugs or a new surgical or radiation technique.
Our translational research includes biomarker and cohort studies, which use patient-derived data to learn more about what causes brain tumors so we can improve treatments. Much of this work is created and led by our team of brain tumor doctors.
The clinical trial program for brain tumors at Miami Cancer Institute is vast and diverse due to our collaborations with several reputable sources, including:
- NRG Oncology
- The Radiation Therapy Oncology Group Foundation
- Children’s Oncology Group
- Various pharmaceutical and biotech organizations
- Individual investigators
- Memorial Sloan Kettering Cancer Alliance – one of the world’s top cancer centers
Learn more about the clinical trials program at the Institute, and find current clinical trials for brain tumors.